• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by UnitedHealth Group Incorporated

    3/27/26 1:52:07 PM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 11)


    UnitedHealth Group Inc

    (Name of Issuer)


    Common Stock

    (Title of Class of Securities)




    91324P102

    (CUSIP Number)
    03/13/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox not checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    91324P102


    1Names of Reporting Persons

    The Vanguard Group
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    PENNSYLVANIA
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    0.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    0.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    0.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    0 %
    12Type of Reporting Person (See Instructions)

    IA

    Comment for Type of Reporting Person:   On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    UnitedHealth Group Inc
    (b)Address of issuer's principal executive offices:

    1 Health Drive, Eden Prairie, MN, 55344
    Item 2. 
    (a)Name of person filing:

    The Vanguard Group
    (b)Address or principal business office or, if none, residence:

    100 Vanguard Blvd.,, Malvern, PA, 19355
    (c)Citizenship:

    PA
    (d)Title of class of securities:

    Common Stock
    (e)CUSIP No.:

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    0
    (b)Percent of class:

    0  %
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    0

     (ii) Shared power to vote or to direct the vote:

    0

     (iii) Sole power to dispose or to direct the disposition of:

    0

     (iv) Shared power to dispose or to direct the disposition of:

    0

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.


    The Vanguard Group, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    The Vanguard Group
     
    Signature:Ashley Grim
    Name/Title:Head of Global Fund Administration
    Date:03/27/2026
    Get the next $UNH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    7/16/2026$453.00Underperform → Neutral
    Robert W. Baird
    6/17/2026$400.00 → $462.00Outperform
    Leerink Partners
    6/4/2026$450.00Neutral → Buy
    BofA Securities
    4/27/2026Hold → Buy
    Erste Group
    4/22/2026$400.00Hold → Buy
    Argus
    4/7/2026$300.00Reduce → Hold
    HSBC Securities
    4/1/2026$330.00Mkt Perform → Outperform
    Raymond James
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Noseworthy John H was granted 206 shares, increasing direct ownership by 3% to 7,616 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    7/6/26 4:46:44 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Montgomery Rice Valerie Md was granted 220 shares, increasing direct ownership by 3% to 7,876 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    7/6/26 4:46:12 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Mcnabb Frederick William Iii was granted 250 shares, increasing direct ownership by 2% to 15,462 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    7/6/26 4:45:36 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UnitedHealth upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded UnitedHealth from Underperform to Neutral and set a new price target of $453.00

    7/16/26 12:59:53 PM ET
    $UNH
    Medical Specialities
    Health Care

    Leerink Partners reiterated coverage on UnitedHealth with a new price target

    Leerink Partners reiterated coverage of UnitedHealth with a rating of Outperform and set a new price target of $462.00 from $400.00 previously

    6/17/26 8:40:31 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth upgraded by BofA Securities with a new price target

    BofA Securities upgraded UnitedHealth from Neutral to Buy and set a new price target of $450.00

    6/4/26 8:41:44 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:47 PM ET
    $UNH
    Medical Specialities
    Health Care

    CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:45 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 12:28:22 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UnitedHealth Group Reports Second Quarter 2026 Results

    Second Quarter 2026 Revenues of $112.0 Billion; Earnings from Operations of $8.0 Billion Earnings of $6.04 Per Share and Adjusted Earnings of $6.38 Per Share Updated Full Year 2026 Earnings Outlook Range to $18.45 to $18.95 Per Share; Adjusted Earnings Range of $19.50 to $20.00 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-reports-second-quarter-2026-results.pdf UnitedHealth Group (NYSE:UNH) today reported second quarter 2026 results and raised guidance for full year 2026. This press release features multimedia. View the full release her

    7/16/26 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealthcare Launches New Spending Account Benefit, Putting More Choice in the Hands of Consumers

    The new Lifestyle Spending Account (LSA) is integrated with UHC Store where eligible members can shop for health, wellness and lifestyle offerings, most at a discount LSA offers employers a flexible, cost-efficient way to help employees customize their experiences with the offerings they value most UnitedHealthcare has introduced a Lifestyle Spending Account (LSA), an employer-sponsored benefit that gives companies a flexible way to help fund and support their employees’ individual health and well-being goals. When offered by an employer, the LSA is designed to help empower people to personalize their experience and shop for products and services to complement their other employer-spons

    7/9/26 9:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealthcare Community Plan of Nebraska Invests $385,000 to Expand Programs to Support Older Adults, Caregivers and People with Disabilities

    Funding supports eight organizations expanding access to care, caregiver resources and workforce opportunities across rural and underserved communities UnitedHealthcare Community Plan of Nebraska is investing $385,000 in eight local organizations to expand access to care, strengthen support for caregivers and older adults, and increase workforce opportunities for people with disabilities, particularly in rural and underserved communities across Nebraska. "Families across Nebraska are finding it harder to access the care and resources they need as demand grows and healthcare workforce shortages continue," said Michael Parnell, RN, CEO of UnitedHealthcare Community Plan of Nebraska. "This

    6/30/26 9:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    SEC Filings

    View All

    UnitedHealth Group Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    7/16/26 6:00:59 AM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form 11-K filed by UnitedHealth Group Incorporated

    11-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    6/11/26 4:55:48 PM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    6/5/26 4:17:52 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    View All

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

    5/13/25 5:59:56 PM ET
    $UNH
    Medical Specialities
    Health Care

    Charlie Baker Joins UnitedHealth Group's Board of Directors

    UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

    11/3/23 4:00:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/13/24 5:16:09 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/24 10:05:20 AM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/23 12:39:51 PM ET
    $UNH
    Medical Specialities
    Health Care

    $UNH
    Financials

    Live finance-specific insights

    View All

    UnitedHealth Group Reports Second Quarter 2026 Results

    Second Quarter 2026 Revenues of $112.0 Billion; Earnings from Operations of $8.0 Billion Earnings of $6.04 Per Share and Adjusted Earnings of $6.38 Per Share Updated Full Year 2026 Earnings Outlook Range to $18.45 to $18.95 Per Share; Adjusted Earnings Range of $19.50 to $20.00 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-reports-second-quarter-2026-results.pdf UnitedHealth Group (NYSE:UNH) today reported second quarter 2026 results and raised guidance for full year 2026. This press release features multimedia. View the full release her

    7/16/26 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

    UnitedHealth Group (NYSE:UNH) provided updates on its 2026 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Scott Gottlieb, M.D., Stephen Hemsley, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting any Board Chair to be independent. At its regular quarterly meeting, the Board of Directors autho

    6/3/26 7:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Reports First Quarter 2026 Results

    First Quarter 2026 Revenues of $111.7 Billion Grew 2% Year-over-Year Earnings of $6.90 Per Share and Adjusted Earnings of $7.23 Per Share Full Year 2026 Earnings Outlook Raised to Greater Than $17.35 Per Share; Adjusted Earnings of Greater Than $18.25 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-reports-first-quarter-2026-results.pdf UnitedHealth Group (NYSE:UNH) today reported first quarter 2026 results, with performance supported by actions taken over the last several quarters. This press release features multimedia. View the full rel

    4/21/26 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care